Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda J Redig

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Cancer|January 15, 2011
Incorporating fertility preservation into the care of young oncology patientsAmanda J Redig, Robert Brannigan, Steven J Stryker, et al.
The Journal of Biological Chemistry|July 8, 2010
Rho-ROCK-myosin signaling mediates membrane type 1 matrix metalloproteinase-induced cellular aggregation of keratinocytesSurabhi Dangi-Garimella, Amanda J Redig, Mario A Shields, et al.
JAMA Oncology|July 9, 2016
Prospective Study of Repeated Biopsy Feasibility and Acquired Resistance at Disease Progression in Patients With Advanced EGFR Mutant Lung Cancer Treated With Erlotinib in a Phase 2 TrialAmanda J Redig, Daniel B Costa, Myriam Taibi, et al.
Cancer Research|May 8, 2007
Suppressive effects of statins on acute promyelocytic leukemia cellsAntonella Sassano, Efstratios Katsoulidis, Giovanni Antico, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2011
Dual mTORC2/mTORC1 targeting results in potent suppressive effects on acute myeloid leukemia (AML) progenitorsJessica K Altman, Antonella Sassano, Surinder Kaur, et al.
JAMA Oncology|January 13, 2018
Immunotherapy and Symptomatic Radiation Necrosis in Patients With Brain Metastases Treated With Stereotactic RadiationAllison M Martin, Daniel N Cagney, Paul J Catalano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2016
Clinical and Molecular Characteristics of NF1-Mutant Lung CancerAmanda J Redig, Marzia Capelletti, Suzanne E Dahlberg, et al.
Molecular Cancer Therapeutics|November 24, 2006
Activation of mammalian target of rapamycin and the p70 S6 kinase by arsenic trioxide in BCR-ABL-expressing cellsPatrick Yoon, Nick Giafis, Jessica Smith, et al.
The Journal of Biological Chemistry|February 13, 2009
Activation of protein kinase C{eta} by type I interferonsAmanda J Redig, Antonella Sassano, Beata Majchrzak-Kita, et al.
The Journal of Biological Chemistry|February 27, 2008
Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2Blazej Dolniak, Efstratios Katsoulidis, Nathalie Carayol, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Cancer|January 15, 2011
Incorporating fertility preservation into the care of young oncology patientsAmanda J Redig, Robert Brannigan, Steven J Stryker, et al.
The Journal of Biological Chemistry|July 8, 2010
Rho-ROCK-myosin signaling mediates membrane type 1 matrix metalloproteinase-induced cellular aggregation of keratinocytesSurabhi Dangi-Garimella, Amanda J Redig, Mario A Shields, et al.
JAMA Oncology|July 9, 2016
Prospective Study of Repeated Biopsy Feasibility and Acquired Resistance at Disease Progression in Patients With Advanced EGFR Mutant Lung Cancer Treated With Erlotinib in a Phase 2 TrialAmanda J Redig, Daniel B Costa, Myriam Taibi, et al.
Cancer Research|May 8, 2007
Suppressive effects of statins on acute promyelocytic leukemia cellsAntonella Sassano, Efstratios Katsoulidis, Giovanni Antico, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2011
Dual mTORC2/mTORC1 targeting results in potent suppressive effects on acute myeloid leukemia (AML) progenitorsJessica K Altman, Antonella Sassano, Surinder Kaur, et al.
JAMA Oncology|January 13, 2018
Immunotherapy and Symptomatic Radiation Necrosis in Patients With Brain Metastases Treated With Stereotactic RadiationAllison M Martin, Daniel N Cagney, Paul J Catalano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2016
Clinical and Molecular Characteristics of NF1-Mutant Lung CancerAmanda J Redig, Marzia Capelletti, Suzanne E Dahlberg, et al.
Molecular Cancer Therapeutics|November 24, 2006
Activation of mammalian target of rapamycin and the p70 S6 kinase by arsenic trioxide in BCR-ABL-expressing cellsPatrick Yoon, Nick Giafis, Jessica Smith, et al.
The Journal of Biological Chemistry|February 13, 2009
Activation of protein kinase C{eta} by type I interferonsAmanda J Redig, Antonella Sassano, Beata Majchrzak-Kita, et al.
The Journal of Biological Chemistry|February 27, 2008
Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2Blazej Dolniak, Efstratios Katsoulidis, Nathalie Carayol, et al.
Pageof 5